The Cell Lysis And Fractionation Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the cell lysis and fractionation has seen significant growth recently. The market will rise from $3.42 billion in 2024 to $3.72 billion in 2025, showing a compound annual growth rate (CAGR) of 8.8%.
The Cell Lysis And Fractionation Global Market is projected to grow to a size of $4.89 billion in 2029, with a compound annual growth rate (CAGR) of 7.0%.
Download Your Free Sample of the 2025 Cell Lysis And Fractionation Market Report and Uncover Key Trends Now!The key drivers in the cell lysis and fractionation market are:
• Growing focus on personalized medicine
• Increasing government funding for genomics and proteomics research
• Rising demand for efficient cell lysis and fractionation methods
• Prevalence of chronic and infectious diseases increasing the need for effective testing mechanisms
The cell lysis and fractionation market covered in this report is segmented –
1) By Type: Mammalian Cells, Microbial Cells
2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation
3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies
The key trends in the cell lysis and fractionation market are:
• A steady increase in the adoption of personalized medicine approaches is a notable trend.
• The integration of automation and robotics in lysis and fractionation processes is an emerging trend.
• There are advancements in microfluidics and lab-on-a-chip technologies for cell analysis, creating a significant shift.
• The emphasis on point-of-care and decentralized testing solutions is a major trend shaping the future of the market.
Major companies in the cell lysis and fractionation market are:
• Hoffmann-La Roche Ltd.
• Merck & Co. Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Becton, Dickinson and Company
• Lonza Group AG
• Illumina Inc.
• Beckman Coulter Inc.
• PerkinElmer Inc.
• IDEX Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN NV
• Eppendorf AG
• Miltenyi Biotec B.V. & Co. KG
• Promega Corporation
• Takara Bio Inc.
• Abcam plc
• Cell Signaling Technology Inc.
• BioVision Inc.
• Diagenode LLC
• Claremont BioSolutions LLC
• Norgen Biotek Corp.
• Qsonica LLC
• Labfreez Instruments Group Co. Ltd.
North America was the largest region in the cell lysis and fractionation market in 2024